首页|丹酚酸B治疗肾脏缺血/再灌注诱导的急性肾损伤的作用机制

丹酚酸B治疗肾脏缺血/再灌注诱导的急性肾损伤的作用机制

扫码查看
目的 通过网络药理学、分子对接和体外实验验证的方法探讨丹酚酸B(Sal B)减轻缺血/再灌注(I/R)诱导的急性肾损伤(AKI)的潜在机制.方法 利用网络药理学,查找Sal B治疗I/R-AKI的核心靶点以及相关通路,利用AutoDock Vina对Sal B和核心靶点进行分子对接.体外实验细胞分为4组[Con、Con+Sal B、缺氧/复氧(H/R)、Sal B+H/R组];用细胞增殖与毒性检测试剂盒(CCK-8)检测细胞活力;用酶联免疫吸附试验(ELISA)法以及反转录-聚合酶链反应(RT-PCR)法检测各组细胞上清中炎症相关因子的含量和细胞炎性因子的mRNA表达情况;流式细胞术检测细胞凋亡率;Western blot检测凋亡蛋白相关因子B细胞淋巴瘤/白血病-2相关X蛋白(bax)、B细胞淋巴瘤/白血病-2(bcl-2)以及裂解的半胱氨酰天冬氨酸特异性蛋白酶-3(cleaved Caspase-3)的表达情况;两组间采用独立样本t检验进行比较.结果 京都基因与基因组百科全书(KEGG)富集分析的信号通路显示,肿瘤坏死因子(TNF)、凋亡等信号通路是Sal B治疗I/R的关键通路.PPI网络分析显示,TNF、CASP3等是Sal B治疗I/R的关键靶点.分子对接结果显示Sal B与TNF、CASP3等靶点有很好的结合力.体外实验发现,Con、H/R组及20、40、80、160 μmol/L Sal B+H/R组(0.42±0.03、0.53±0.02、0.54±0.04、0.48±0.02)细胞活力高于 H/R 组(0.38±0.01),差异有统计学意义(t=2.8、15.1、8.6、10.2,P<0.05);Sal B+H/R 组炎性因子 TNF-α、IL-6、IL-I β[(277.06±6.80)、(4.69±1.04)ng/L、(0.62±0.53)pg/L]含量低于 H/R 组[(388.59±9.01)、(22.03±0.56)ng/L、(41.81±1.49)pg/L],高于 Con 组[(217.59±6.26)、(15.88±0.62)ng/L、(32.89±1.01)pg/L],差异有统计学意义(t=17.4、25.4、45.1、17.1、16.1、49.4,P<0.05).Sal B+H/R 组细胞中炎性因子 TNF-α、IL-6、IL-1 β 的 mRNA 表达水平(2.59±0.39、1.61±0.15、2.09±1.30)低于H/R 组(3.79±0.28、2.36±0.50、1.17±0.59),差异有统计学意义(t=4.3、2.5、1.2,P<0.05).Sal B+H/R 组的 HK-2 细胞凋亡率、cleaved Caspase-3 及 bax/bcl-2 蛋白表达量[(4.43±0.68)%、1.19±0.09、0.99±0.11]低于 H/R 组[(12.06±0.14)%、1.98±0.12、4.16±0.52],差异有统计学意义(t=19.0、25.4、45.1,P<0.05).结论 Sal B可以缓解H/R引发的肾小管上皮细胞炎症和凋亡反应,从而缓解I/R-AKI的进程.
Study on the mechanism of salvianolic acid B in the treatment of renal ischemia/reperfusion-induced acute renal injur
Objective This study aims to explore the potential mechanism of Salvianolic acid B(Sal B)in alleviating ischemia/reperfusion(I/R)-induced acute kidney injury(AKI)through network pharmacology,molecular docking,and in vitro experiments.Methods Network pharmacology was used to find the core target and related pathway of Sal B in the treatment of I/R-AKI,and AutoDock Vina was used for molecular docking of Sal B and core target.The cells were divided into 4 groups[Con group,Con+Sal B group,hypoxia/reoxygenation(H/R)group,Sal B+H/R group].Cell viability was measured by cell counting kit-8(CCK-8)method.Enzyme-linked immunosorbent assay(ELISA)and reverse transcriptase-polymerase chain reaction(RT-PCR)were used to detect the content of inflammation-related factors and the mRNA expression of inflammatory factors in the cell supernatants of each group.The apoptosis rate was de-tected by flow cytometry.The expressions of B cell lymphoma/leukemia-2 associated X protein(bax),B cell lymphoma/leukemia-2(bcl-2)and cleaved cysteinyl aspartate-specific protease-3(cleaved Caspase-3)were detected by Western blotting.T-test was used to compare the two groups.Results The signal path-ways of kyoto encyclopedia of genes and genomes(KEGG)enrichment analysis showed that tumour necrosis factor(TNF),apoptosis and other signal pathways were the key pathways of Sal B treatment of I/R.PPI network analysis showed that TNF and CASP3 were key targets of I/R treatment for Sal B.Molecular doc-king results showed that SalB had good binding force with TNF,CASP3 and other targets.In vitro experi-ments showed that the cell viability of Con group,H/R group and 20,40,80,160 μmol/L Sal B+H/R group(0.42±0.03,0.53±0.02,0.54±0.04,0.48±0.02)was higher than that of H/R group(0.38±0.01).The difference was statistically significant(t=2.8,15.1,8.6,10.2,P<0.05).Sal B+H/R group of inflammatory factor TNF alpha beta,IL-6,IL-1[(277.06±6.80),(4.69±1.04)ng/L,(0.62±0.53)pg/L]content below H/R group[(388.59±9.01),(22.03±0.56)ng/L,(41.81±1.49)pg/L],higher than in Con group[(217.59±6.26),(15.88±0.62)ng/L,(32.89±1.01)pg/L],statistically significant difference(t=17.4,25.4,45.1,P<0.05 and t=17.1,16.1,49.4,P<0.05).The mRNA expression levels of inflammatory factors TNF-α,IL-6 and IL-1β in Sal B+H/R group(2.59±0.39,1.61±0.15,2.09±1.30)were lower than those in H/R group(3.79±0.28,2.36±0.50,1.17±0.59).The difference was statistically significant(t=4.3,2.5,1.2,P<0.05).The apoptosis rate of HK-2 cells,the expression of cleaved Caspase-3 and bax/bcl-2 protein[(4.43±0.68)%,1.19±0.09,0.99±0.11]in Sal B+H/R group were lower than those in H/R group[(12.06±0.14)%,1.98±0.12,4.16±0.52],the difference was statistically significant(t=19.0,25.4,45.1,P<0.05).Conclusion To explore the potential mechanism by which Sal B alleviates ische-mia/reperfusion(I/R)-induced AKI through network pharmacology,molecular docking,and in vitro exper-iments.

Salvianolic acid BNetwork pharmacologyMolecular dockingApoptosisAcute kidney injury

赵静宇、范秀照、韩秀涛、陈发慧、田瑞雪、任茜雅、白梦琦、周晓霜

展开 >

山西省人民医院肾内科,太原 030012

山西中医药大学第三临床学院,太原 030024

丹酚酸B 网络药理学 分子对接 凋亡 急性肾损伤

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(12)